Related references
Note: Only part of the references are listed.Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a multicentre, randomized, observer-blind phase III study in comparison with a registered methyl-5-aminolaevulinate cream and placebo
T. Dirschka et al.
BRITISH JOURNAL OF DERMATOLOGY (2012)
Ingenol Mebutate Gel for Actinic Keratosis
Mark Lebwohl et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Long-term follow-up of photodynamic therapy with a self-adhesive 5-aminolaevulinic acid patch: 12 months data
R. -M. Szeimies et al.
BRITISH JOURNAL OF DERMATOLOGY (2010)
Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a prospective, randomized, double-blind, placebo-controlled phase III study
R. -M. Szeimies et al.
BRITISH JOURNAL OF DERMATOLOGY (2010)
Fluorescence induction of protoporphyrin IX by a new 5-aminolevulinic acid nanoemulsion used for photodynamic therapy in a full-thickness ex vivo skin model
Tim Maisch et al.
EXPERIMENTAL DERMATOLOGY (2010)
Optimization of photodynamic therapy with a novel self-adhesive 5-aminolaevulinic acid patch: results of two randomized controlled phase III studies
A. Hauschild et al.
BRITISH JOURNAL OF DERMATOLOGY (2009)
Short incubation with methyl aminolevulinate for photodynamic therapy of actinic keratoses
L. R. Braathen et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2009)
Actinic keratosis is an early in situ squamous cell carcinoma:: a proposal for reclassification
J. Roewert-Huber et al.
BRITISH JOURNAL OF DERMATOLOGY (2007)
Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: An international consensus
Lasse R. Braathen et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2007)
Photodynamic therapy using aminotaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow up
E. H. Tschen et al.
BRITISH JOURNAL OF DERMATOLOGY (2006)
Share Paper
